These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28498637)
41. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis. Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563 [TBL] [Abstract][Full Text] [Related]
42. Extracellular NAMPT/visfatin causes p53 deacetylation via NAD production and SIRT1 activation in breast cancer cells. Behrouzfar K; Alaee M; Nourbakhsh M; Gholinejad Z; Golestani A Cell Biochem Funct; 2017 Aug; 35(6):327-333. PubMed ID: 28845527 [TBL] [Abstract][Full Text] [Related]
43. Bone Marrow-Derived Mesenchymal Stem Cells Promoted Cutaneous Wound Healing by Regulating Keratinocyte Migration via β Huo J; Sun S; Geng Z; Sheng W; Chen R; Ma K; Sun X; Fu X Mol Pharm; 2018 Jul; 15(7):2513-2527. PubMed ID: 29757659 [TBL] [Abstract][Full Text] [Related]
44. β2-Adrenergic Receptor Signaling Pathway Stimulates the Migration and Invasion of Cancer Cells via Src Activation. Jeong JH; Park HJ; Park SH; Choi YH; Chi GY Molecules; 2022 Sep; 27(18):. PubMed ID: 36144682 [TBL] [Abstract][Full Text] [Related]
45. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression. Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251 [TBL] [Abstract][Full Text] [Related]
46. TWEAK increases SIRT1 expression and promotes p53 deacetylation affecting human hepatic stellate cell senescence. Zhang F; Zhang M; Wang A; Xu M; Wang C; Xu G; Zhang B; Zou X; Zhuge Y Cell Biol Int; 2017 Feb; 41(2):147-154. PubMed ID: 27888541 [TBL] [Abstract][Full Text] [Related]
47. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling. Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368 [TBL] [Abstract][Full Text] [Related]
48. Sirt1 attenuates camptothecin-induced apoptosis through caspase-3 pathway in porcine preadipocytes. Pang WJ; Xiong Y; Wang Y; Tong Q; Yang GS Exp Cell Res; 2013 Mar; 319(5):670-83. PubMed ID: 23313858 [TBL] [Abstract][Full Text] [Related]
49. Sirtuin1 (SIRT1) in the Acetylation of Downstream Target Proteins. Gomes AR; Yong JS; Kiew KC; Aydin E; Khongkow M; Laohasinnarong S; Lam EW Methods Mol Biol; 2016; 1436():169-88. PubMed ID: 27246215 [TBL] [Abstract][Full Text] [Related]
50. Sirt1 overexpression suppresses fluoride-induced p53 acetylation to alleviate fluoride toxicity in ameloblasts responsible for enamel formation. Suzuki M; Ikeda A; Bartlett JD Arch Toxicol; 2018 Mar; 92(3):1283-1293. PubMed ID: 29185024 [TBL] [Abstract][Full Text] [Related]
51. P53 and Sirt1: routes of metabolism and genome stability. Gonfloni S; Iannizzotto V; Maiani E; Bellusci G; Ciccone S; Diederich M Biochem Pharmacol; 2014 Nov; 92(1):149-56. PubMed ID: 25218422 [TBL] [Abstract][Full Text] [Related]
52. Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65. Shinozaki S; Chang K; Sakai M; Shimizu N; Yamada M; Tanaka T; Nakazawa H; Ichinose F; Yamada Y; Ishigami A; Ito H; Ouchi Y; Starr ME; Saito H; Shimokado K; Stamler JS; Kaneki M Sci Signal; 2014 Nov; 7(351):ra106. PubMed ID: 25389371 [TBL] [Abstract][Full Text] [Related]
53. Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target. Asaka R; Miyamoto T; Yamada Y; Ando H; Mvunta DH; Kobara H; Shiozawa T Lab Invest; 2015 Dec; 95(12):1363-73. PubMed ID: 26367491 [TBL] [Abstract][Full Text] [Related]
54. Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells. Lee SJ; Hwang SO; Noh EJ; Kim DU; Nam M; Kim JH; Nam JH; Hoe KL Exp Mol Med; 2014 Feb; 46(2):e76. PubMed ID: 24525822 [TBL] [Abstract][Full Text] [Related]
55. Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity. Knight JR; Allison SJ; Milner J Open Biol; 2013 Nov; 3(11):130130. PubMed ID: 24258275 [TBL] [Abstract][Full Text] [Related]
56. Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer. Kiga K; Fukuda-Yuzawa Y; Tanabe M; Tsuji S; Sasakawa C; Fukao T RNA Biol; 2014; 11(11):1347-54. PubMed ID: 25483038 [TBL] [Abstract][Full Text] [Related]
57. AG1031 induces apoptosis through suppressing SIRT1/p53 pathway in human neuroblastoma cells. Fu J; Zhang H; Zhang Y; Zhang T Mol Cell Biochem; 2019 Apr; 454(1-2):165-175. PubMed ID: 30350304 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA‑138‑5p drives the progression of heart failure via inhibiting sirtuin 1 signaling. Sun S; Wang C; Weng J Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576462 [TBL] [Abstract][Full Text] [Related]
59. Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1). Liu X; Wang D; Zhao Y; Tu B; Zheng Z; Wang L; Wang H; Gu W; Roeder RG; Zhu WG Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1925-30. PubMed ID: 21245319 [TBL] [Abstract][Full Text] [Related]
60. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair. Barckhausen C; Roos WP; Naumann SC; Kaina B Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]